Dr. Aniruddha M. Pawar MD (Internal Medicine), DM (Cardiology), FSCAI

Dr. Aniruddha Pawar is an experienced Interventional Cardiologist with over 7 years of dedicated cardiology practice. Trained at some of Mumbai’s most reputed institutions like Topiwala National Medical College & BYL Nair Hospital, and Seth G.S. Medical College & KEM Hospital; he combines strong academic pedigree with advanced clinical expertise.

He specializes in complex coronary and structural heart interventions and is known for a patient-centric approach that blends precision with compassion.

• DM (Cardiology) – Seth G.S. Medical College & KEM Hospital, Mumbai (2018)
• MD (Internal Medicine) – Topiwala National Medical College & BYL Nair Hospital, Mumbai (2015)
• Meril: Certified TAVR Proctor — Myval transcatheter heart valve system (2026)

• Consultant Interventional Cardiologist – Bethany Hospital, Kaushalya Hospital, Shri Mahavir Jain Hospital (since 2020)
• Assistant Professor, Department of Cardiology – KEM Hospital, Mumbai

• Coronary Angiography & Angioplasty
• Management of Acute Coronary Syndromes
• Pacemaker Implantation & Device Therapies
• Structural Interventions Including Valve and Congenital Procedures
• Advanced Echocardiography and Non-invasive Cardiac Imaging

• Original Article: Validation of ‘Left Ventricular Early Inflow-Outflow Index’ – Indian Heart Journal, 2018
 
• Case Reports published in European Heart Journal, Interventional Cardiology Journal, IHJ Cardiovascular Case Reports, covering topics such as:
• SA nodal dysfunction
• Loeffler’s endocarditis
• Amyloid cardiomyopathy as initial presentation of multiple myeloma
• Angina equivalents and rare congenital heart disease presentations
 
• Poster Presentations:
• His bundle pacing (Indian Society of Electrocardiology, 2019)
• Novel quantification of mitral regurgitation (CSI, Kolkata, 2017)
 
• Textbook Contributions:
• Exercise Testing – API Textbook of Medicine (11th Ed.)
• Coronary Intervention in Venous Grafts – Cardio Diabetes Update (2017)
 
• Research Role: Co-investigator in ODYSSEY EAST Trial (Alirocumab vs. Ezetimibe in high-risk patients with hypercholesterolemia).

• Member, Cardiology Society of India (since 2019)
• Fellow, Society for Cardiovascular Angiography & Intervention (FSCAI) (2024)